D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 55,563 420 World Ranking 12594 National Ranking 446

Best Publications

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Roger Stupp;Warren P. Mason;Martin J. van den Bent;Michael Weller.
The New England Journal of Medicine (2005)

19131 Citations

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Roger Stupp;Monika E. Hegi;Warren P. Mason;Martin J. van den Bent.
Lancet Oncology (2009)

9394 Citations

Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma

Olivier L. Chinot;Wolfgang Wick;Warren Mason;Roger Henriksson.
The New England Journal of Medicine (2014)

2215 Citations

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Martin J. van den Bent;Alba A. Brandes;Martin J.B. Taphoorn;Johan M. Kros.
Journal of Clinical Oncology (2013)

1101 Citations

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp;Roger Stupp;Monika E Hegi;Thierry Gorlia;Sara C Erridge.
Lancet Oncology (2014)

976 Citations

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Martin J. van den Bent;Antoine F. Carpentier;Alba A. Brandes;Marc Sanson.
Journal of Clinical Oncology (2006)

955 Citations

MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

Alba A. Brandes;Enrico Franceschi;Alicia Tosoni;Valeria Blatt.
Journal of Clinical Oncology (2008)

860 Citations

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?

Michael Weller;Roger Stupp;Guido Reifenberger;Alba A. Brandes.
Nature Reviews Neurology (2010)

732 Citations

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

James R. Perry;Normand Laperriere;Christopher J. O'Callaghan;Alba A. Brandes.
The New England Journal of Medicine (2017)

700 Citations

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

Andrés J. M. Ferreri;Michele Reni;Marco Foppoli;Maurizio Martelli.
The Lancet (2009)

626 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Alba A. Brandes

Michael Weller

Michael Weller

University of Zurich

Publications: 279

Patrick Y. Wen

Patrick Y. Wen

Harvard University

Publications: 271

Wolfgang Wick

Wolfgang Wick

German Cancer Research Center

Publications: 270

David A. Reardon

David A. Reardon

Harvard University

Publications: 211

Timothy F. Cloughesy

Timothy F. Cloughesy

University of California, Los Angeles

Publications: 173

Mark R. Gilbert

Mark R. Gilbert

National Institutes of Health

Publications: 170

Martin J. van den Bent

Martin J. van den Bent

Erasmus University Rotterdam

Publications: 150

Roger Stupp

Roger Stupp

Northwestern University

Publications: 145

Jeremy N. Rich

Jeremy N. Rich

University of Pittsburgh

Publications: 139

Susan M. Chang

Susan M. Chang

University of California, San Francisco

Publications: 132

Tracy T. Batchelor

Tracy T. Batchelor

Brigham and Women's Hospital

Publications: 120

John H. Sampson

John H. Sampson

Duke University

Publications: 113

Andreas von Deimling

Andreas von Deimling

Heidelberg University

Publications: 103

Kenneth D. Aldape

Kenneth D. Aldape

Princess Margaret Cancer Centre

Publications: 102

Mitchel S. Berger

Mitchel S. Berger

University of California, San Francisco

Publications: 92

Justin D. Lathia

Justin D. Lathia

Cleveland Clinic Lerner College of Medicine

Publications: 89

Trending Scientists

Chester S. Spatt

Chester S. Spatt

Carnegie Mellon University

Richard Y. K. Fung

Richard Y. K. Fung

City University of Hong Kong

Holger Gohlke

Holger Gohlke

Heinrich Heine University Düsseldorf

Brian C. Benicewicz

Brian C. Benicewicz

University of South Carolina

James R. Maxwell

James R. Maxwell

University of Bristol

Ranieri Rossi

Ranieri Rossi

University of Siena

Joseph D. Buxbaum

Joseph D. Buxbaum

Icahn School of Medicine at Mount Sinai

Mathieu Joron

Mathieu Joron

University of Montpellier

Kaj Sand-Jensen

Kaj Sand-Jensen

University of Copenhagen

Michael E. Hood

Michael E. Hood

Amherst College

Dirk Offermann

Dirk Offermann

University of Wuppertal

Mark J. Shlomchik

Mark J. Shlomchik

University of Pittsburgh

Leslie D. Leve

Leslie D. Leve

University of Oregon

Frank W. Putnam

Frank W. Putnam

University of North Carolina at Chapel Hill

dennis j slamon

dennis j slamon

University of California, Los Angeles

Leonardo Pantoni

Leonardo Pantoni

University of Milan

Something went wrong. Please try again later.